Form 4: Quaker Chemical Grants VP Meagher 297 RSUs
Insider Transaction Report
Quaker Chemical Corp. granted 297 Restricted Stock Units to VP Kevin K. Meagher, vesting annually starting March 15, 2027.
Summary
- Kevin K. Meagher, VP, R&D Advanced Solutions at Quaker Chemical Corp. (KWR), was granted 297 Restricted Stock Units (RSUs).
- These RSUs were granted under the Company's Long-Term Performance Incentive Plan.
- The RSUs are time-based and will vest in three annual installments, with the first vesting date on March 15, 2027.
- Each RSU represents a contingent right to receive one share of KWR common stock.
- Dividend Equivalent Rights (DERs) will accrue with respect to these RSUs when and as dividends are paid on KWR common stock.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine executive compensation and retention efforts, which are generally beneficial for corporate stability and long-term strategic execution.
Positives
- Granting of RSUs aligns the interests of a key executive, Kevin K. Meagher, with those of shareholders, incentivizing long-term performance and retention.
- The use of a Rule 10b5-1(c) plan indicates a pre-arranged and transparent approach to executive compensation.
Future Outlook
The granted Restricted Stock Units are designed to vest in three annual installments beginning on March 15, 2027, indicating a future incentive structure for the executive.
Industry Context
StockSavvy.ai notes that the granting of Restricted Stock Units is a standard practice in executive compensation across various industries, particularly in specialty chemicals, to attract, retain, and incentivize key talent by aligning their long-term interests with shareholder value creation. This type of equity award is common for senior executives like a VP of R&D.
Comparison to Industry Standards
- This RSU grant is consistent with typical executive compensation practices in the specialty chemicals sector, where companies like PPG Industries, Sherwin-Williams, and RPM International frequently utilize equity awards to incentivize long-term performance.
- The structure of time-based vesting over multiple years is a common mechanism to promote executive retention and sustained strategic focus, aligning with global benchmarks for executive incentive plans.
Stakeholder Impact
- Shareholders: The grant aligns executive interests with shareholder value creation, potentially leading to improved long-term performance.
- Employees: This reflects the company's ongoing executive compensation strategy, which can influence overall employee morale and retention strategies.
Next Steps
- The granted RSUs will vest in three annual installments beginning on March 15, 2027.
- Dividend Equivalent Rights (DERs) will accrue when and as dividends are paid on KWR common stock.
Key Dates
| Date | Description |
|---|---|
| 03/15/2026 | Date of RSU grant to Kevin K. Meagher. |
| 03/17/2026 | Date the Form 4 was signed by Attorney-in-Fact for Kevin K. Meagher. |
| 03/15/2027 | First annual vesting date for the granted Restricted Stock Units. |
Recommendation
holdThis Form 4 filing reports a routine executive equity grant and does not contain information significant enough to alter an investment thesis. It reflects standard compensation practices aimed at executive retention and alignment, which are generally positive but not a catalyst for a 'buy' or 'sell' recommendation on their own.
Keywords
Quaker Chemical Corp, KWR, Form 4, Restricted Stock Units, RSU, Executive Compensation, Kevin K. Meagher, Insider Transaction, Equity Grant, Long-Term Incentive Plan, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.